Ancient Chinese formula Qiong-Yu-Gao protects against cisplatin-induced nephrotoxicity without reducing anti-tumor activity

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Teng, Zhi Ying ^a,b   Cheng, Xiao Lan ^a,b   Cai, Xue Ting ^a,b   Yang, Yang ^a,b   Sun, Xiao Yan ^a,b   Xu, Jin Di ^b   Lu, Wu Guang ^a,b   Chen, Jiao ^a,b   Hu, Chun Ping ^a,b   Zhou, Qian ^a,b   Wang, Xiao Ning ^b   Li, Song Lin ^b   Cao, Peng ^a,b  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b Jiangsu Province Academy of Traditional Chinese Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOOXYGENASE 2; HERBACEOUS AGENT; IL1B PROTEIN, MOUSE; INTERLEUKIN 1BETA; PTGS2 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR;

ANIMAL; BIOSYNTHESIS; CARCINOMA, LEWIS LUNG; CHEMICALLY INDUCED; DRUG EFFECTS; GENE EXPRESSION REGULATION; KIDNEY DISEASES; METABOLISM; MOUSE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; CISPLATIN; CYCLOOXYGENASE 2; DRUGS, CHINESE HERBAL; GENE EXPRESSION REGULATION; INTERLEUKIN-1BETA; KIDNEY DISEASES; MICE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84946117568     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep15592     Document Type: Article

References (51)

1. Wang, D. and Lippard, S. J. Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov. 4, 307-320 (2005).
2. Bagri, P. K. et al. Comparative analysis of cisplatin-induced nephrotoxicity in head and neck cancer and carcinoma cervix during concurrent chemoradiotherapy. South Asian J Cancer 3, 217-220 (2014).
3. Pabla, N. and Dong, Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int. 73, 994-1007 (2008).
4. dos Guinaim Santos, N. A., Carvalho Rodrigues, M. A., Martins, N. M. and dos Santos, A. C. Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update. Arch Toxicol. 86, 1233-1250 (2012).
5. Oh, G. S. et al. Pharmacological activation of NQO1 increases NAD+ levels and attenuates cisplatin-mediated acute kidney injury in mice. Kidney Int. 85, 547-560 (2014).
6. Yao, X., Panichpisal, K., Kurtzman, N. and Nugent, K. Cisplatin nephrotoxicity: a review. Am J. Med Sci 334, 115-124 (2007).
7. Pabla, N. and Dong, Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int. 73, 994-1007 (2008).
8. Miller, R. P., Tadagavadi, R. K., Ramesh, G. and Reeves, W. B. Mechanisms of Cisplatin nephrotoxicity. Toxins (Basel) 2, 2490-2518 (2010).
9. Ulu, R. et al. Regulation of renal organic anion and cation transporters by thymoquinone in cisplatin induced kidney injury. Food Chem Toxicol 50, 1675-1679 (2012).
10. Hinai, Y., Motoyama, S., Niioka, T. and Miura, M. Absence of effect of SLC22A2 genotype on cisplatin-induced nephrotoxicity in oesophageal cancer patients receiving cisplatin and 5-fluorouracil: report of results discordant with those of earlier studies. J Clin Pharm Ther 38, 498-503 (2013).
11. Yao, X., Panichpisal, K., Kurtzman, N. and Nugent, K. Cisplatin nephrotoxicity: a review. Am J Med Sci. 334, 115-124 (2007).
12. Kidera, Y. et al. Risk factors for cisplatin-induced nephrotoxicity and potential of magnesium supplementation for renal protection. PLoS One 9, e101902 (2014).
13. Uehara, T., Yamate, J., Torii, M. and Maruyama, T. Comparative nephrotoxicity of Cisplatin and nedaplatin: mechanisms and histopathological characteristics. J Toxicol Pathol. 24, 87-94 (2011).
14. Liu, H. L. and Qu, W. L. Advance of ancient literature research on Qiong-yu-gao. Shaanxi J Tradit Chin Med 9, 1231-1232 (2010).
15. Xu, J. D. et al. Ultra-high performance liquid chromatography coupled withphoto-diode array and quadrupole/time-of-flight mass spectrometrybased chemical profiling approach to evaluate the influence ofpreparation methods on the holistic quality of Qiong-Yu-Gao,a traditional complex herbal medicine. J Chromatogr A 1304, 154-168 (2013).
16. Zhang, R. X., Li, M. X. and Jia, Z. P. Rehmannia glutinosa: review of botany, chemistry and pharmacology. J Ethnopharmacol 117, 199-214 (2008).
17. Ros, J. L. Chemical constituents and pharmacological properties of Poria cocos. Planta Med 77, 681-691 (2011).
18. Liu, H. L and Qu, W. L. Advance of modern research on Qiong-yu-gao. Nei Mongol J Tradit Chin Med 16, 109-110 (2010).
19. Ye, Y. et al. Screening of Chinese herbal medicines for antityrosinase activity in a cell free system and B16 cells. J Ethnopharmacol 16, 387-390 (2010).
20. Xue, Y. F. and Li, Z. B. Effects of Qiong-yu-gao on the nervous system in a mouse model of aging. Tradit Chin Drug Res and Clin Pharmacolo 10, 159-161 (1999).
21. Shen, X. Y., Xia, F. and Xu, Y. S. Qiongyugao for the bone marrow inhibition of mice with pulmonary adenocarcinoma. Chin J Clin Rehab 9, 259-261 (2005).
22. Lee, B. C., Choi, J. B., Cho, H. J. and Kim, Y. S. Rehmannia glutinosa ameliorates the progressive renal failure induced by 5/6 nephrectomy. J Ethnopharmacol 122, 131-135 (2009).
23. Kang, D. G., Sohn, E. J., Moon, M. K., Lee, Y. M. and Lee, H. S. Rehmannia glutinose ameliorates renal function in the ischemia/ reperfusion-induced acute renal failure rats. Biol Pharm Bull 28, 1662-1667 (2005).
24. Zhao, Y. Y., Lei, P., Chen, D. Q., Feng, Y. L. and Bai, X. Renal metabolic profiling of early renal injury and renoprotective effects of Poria cocos epidermis using UPLC Q-TOF/HSMS/MSE. J Pharm Biomed Anal 81-82, 202-109 (2013).
25. Zhao, Y. Y., Li, H. T., Feng, Y. L., Bai, X. and Lin, R. C. Urinary metabonomic study of the surface layer of Poria cocos as an effective treatment for chronic renal injury in rats. J Ethnopharmacol 148, 403-410 (2013).
26. Shin, H. S., Yu, M., Kim, M., Choi, H. S. and Kang, D. H. Renoprotective effect of red ginseng in gentamicin-induced acute kidney injury. Lab Invest 94, 1147-1160 (2014).
27. Kim, Y. J. et al. Red ginseng ameliorates acute cisplatin-induced nephropathy. Planta Med 80, 645-654 (2014).
28. Dong, Z. and Chen, C. X. Effect of catalpol on diabetic nephropathy in rats. Phytomedicine 20, 1023-1029 (2013).
29. Zhou, J. et al. Protective effect of ginsenoside against acute renal failure via reduction of renal oxidative stress and enhanced expression of ChAT in the proximal convoluted tubule and ERK1/2 in the paraventricular nuclei. Physiol Res 63, 597-604 (2014).
30. Oh, G. S. et al. Pharmacological activation of NQO1 increases NAD+ levels and attenuates cisplatin-mediated acute kidney injury in mice. Kidney Int, 85, 547-560 (2014).
31. Qi, S. and Wu, D. Bone marrow-derived mesenchymal stem cells protect against cisplatin-induced acute kidney injury in rats by inhibiting cell apoptosis. Int J Mol Med 32, 1262-1272 (2013).
32. Verbanac, D. et al. Determination of standard zincvalues in the intact tissues of mice by ICP spectrometry. Biol Trace Elem Res 57, 91-96 (1997).
33. Wang, H. et al. The pseudoginsenoside F11 ameliorates cisplatin-induced nephrotoxicity without compromising its anti-tumor activity in vivo. Sci Rep 4, 4986-4991 (2014).
34. Ramesh, G. and Reeves, W. B. Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-α . Kidney Int 65, 490-498 (2004).
35. Pabla, N. and Dong, Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 73, 994-1007 (2008).
36. Kannan, K. and Jain, S. K. Oxidative stress and apoptosis. Pathophysiology 7, 153-163 (2000).
37. Miller, R. P., Tadagavadi, R. K., Ramesh, G. and Reeves, W. B. Mechanisms of cisplatin nephrotoxicity. Toxins (Basel) 2, 2490-2518 (2010).
38. Kim, J. H. et al. Human adipose tissue-derived mesenchymal stem cells protect kidneys from cisplatin nephrotoxicity in rats. Am J Physiol Renal Physiol 302, 1141-1150 (2012).
39. Jia, Z. et al. Amelioration of cisplatin nephrotoxicity by genetic or pha rmacologic blockade of prostaglandin synthesis. Kidney Int 2011, 77-88 (2011).
40. Domitrovic, R. et al. Berberine exerts nephroprotective effect against cisplatin-induced kidney damage through inhibition of oxidative/nitrosative stress, inflammation, autophagy and apoptosis. Food Chem Toxicol 2, 397-406 (2013).
41. Ueki, M., Ueno, M., Morishita, J. and Maekawa, N. Curcumin ameliorates cisplatin-induced nephrotoxicity by inhibiting renal inflammation in mice. J Biosci Bioeng 115, 547-551 (2013).
42. Amin, A. et al. A standardized extract of Ginkgo biloba neutralizes cisplatin-mediated reproductive toxicity in rats. J Biomed Biotechnol 2012, 362049 (2012).
43. Wei, Q. et al. Activation and involvement of p53 in cisplatin-induced nephrotoxicity. Am J Physiol Ren Physiol 2293, 1282-1291 (2007).
44. Zhou, H. et al. The induction of cell cycle regulatory and DNA repair proteins in cisplatin-induced acute renal failure. Toxicol Appl Pharmacol 200, 111-120 (2004).
45. Filipski, K. K., Mathijssen, R. H., Mikkelsen, T. S., Schinkel, A. H. and Sparreboom, A. Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity. Clin Pharmacol Ther 86, 396-402 (2009).
46. Ciarimboli, G. et al. Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions. Am J Pathol 176, 1169-1180 (2010).
47. Pabla, N., Murphy, R. F., Liu, K. and Dong, Z. The copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicity. J Physiol Renal Physiol 296, 505-511 (2009).
48. Ju, S. M. et al. The Flavonoid Apigenin Ameliorates Cisplatin-Induced Nephrotoxicity through Reduction of p53 Activation and Promotion of PI3K/Akt Pathway in Human Renal Proximal Tubular Epithelial Cells. Evid Based Complement Alternat Med 2015, 186436 (2015).
49. Kim, T. W. et al. Chrysanthemum indicum attenuates cisplatin-induced nephrotoxicity both in vivo and in vitro. Nat Prod Commun 10, 397-402 (2015).
50. Kim, H. J. et al. Glutamine protects against cisplatin-induced nephrotoxicity by decreasing cisplatin accumulation. J Pharmacol Sci 127, 117-26 (2015).
51. Yousef, M. I. and Hussien, H. M. Cisplatin-induced renal toxicity via tumor necrosis factor-α , interleukin 6, tumor suppressor P53, DNA damage, xanthine oxidase, histological changes, oxidative stress and nitric oxide in rats: protective effect of ginseng. Food Chem Toxicol 78, 17-25 (2015).